A detailed history of Cidel Asset Management Inc transactions in Pfizer Inc stock. As of the latest transaction made, Cidel Asset Management Inc holds 51,732 shares of PFE stock, worth $1.44 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
51,732
Previous 45,159 14.56%
Holding current value
$1.44 Million
Previous $1.3 Million 10.38%
% of portfolio
0.12%
Previous 0.06%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

BUY
$25.89 - $29.73 $170,174 - $195,415
6,573 Added 14.56%
51,732 $1.44 Million
Q4 2023

Feb 12, 2024

BUY
$26.13 - $33.94 $1.18 Million - $1.53 Million
45,159 New
45,159 $1.3 Million
Q1 2022

May 10, 2022

SELL
$45.75 - $56.69 $53,939 - $66,837
-1,179 Reduced 14.48%
6,965 $361,000
Q3 2021

Nov 05, 2021

SELL
$39.25 - $50.42 $7,889 - $10,134
-201 Reduced 2.41%
8,144 $350,000
Q2 2021

Aug 10, 2021

SELL
$35.91 - $40.68 $54,331 - $61,548
-1,513 Reduced 15.35%
8,345 $327,000
Q1 2021

May 12, 2021

SELL
$33.49 - $37.77 $61,286 - $69,119
-1,830 Reduced 15.66%
9,858 $357,000
Q4 2020

Feb 16, 2021

BUY
$33.47 - $42.56 $102,384 - $130,191
3,059 Added 35.45%
11,688 $430,000
Q2 2020

Aug 12, 2020

BUY
$30.12 - $36.54 $61,143 - $74,176
2,030 Added 30.76%
8,629 $282,000
Q1 2020

May 12, 2020

SELL
$27.03 - $38.62 $41,139 - $58,779
-1,522 Reduced 18.74%
6,599 $215,000
Q4 2019

Feb 14, 2020

SELL
$32.92 - $37.36 $1.28 Million - $1.45 Million
-38,850 Reduced 82.71%
8,121 $318,000
Q3 2019

Nov 12, 2019

BUY
$32.49 - $42.13 $1.53 Million - $1.98 Million
46,971 New
46,971 $1.69 Million
Q2 2019

Aug 08, 2019

SELL
$36.98 - $41.52 $341,251 - $383,146
-9,228 Closed
0 $0
Q1 2019

May 06, 2019

SELL
$37.5 - $41.2 $28,125 - $30,900
-750 Reduced 7.52%
9,228 $392,000
Q4 2018

Feb 08, 2019

BUY
$38.47 - $43.86 $21,158 - $24,123
550 Added 5.83%
9,978 $436,000
Q2 2018

Aug 13, 2018

BUY
$32.98 - $35.16 $310,935 - $331,488
9,428 New
9,428 $342,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $157B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Cidel Asset Management Inc Portfolio

Follow Cidel Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cidel Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cidel Asset Management Inc with notifications on news.